Ibumetin Express (Ibuprofen)

Ibuprofen acts systemically to reduce pain, fever and inflammation across several common conditions.

• Mild to moderate pain: provides analgesia by lowering pain‑signal intensity.
• Fever: reduces elevated body temperature through central thermoregulatory effects.
• Arthritis and other inflammatory disorders: diminishes joint swelling and stiffness by limiting inflammatory mediators.

• Ibuprofen exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis reduces inflammation, lowers fever, and attenuates pain signaling pathways throughout the body.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or heartburn.
• Headache or dizziness.
• Mild skin rash or itching.
• Elevated blood pressure in some individuals.
• Transient increase in serum creatinine.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Severe allergic reactions including anaphylaxis.
• Hepatotoxicity with elevated liver enzymes.
• Acute kidney injury, especially in dehydrated patients.
• Cardiovascular events such as myocardial infarction or stroke.
• Blood dyscrasias like thrombocytopenia.

Before initiating ibuprofen therapy, consider the following safety measures.

• Assess renal function: avoid or adjust dose in patients with impaired kidney function.
• Evaluate gastrointestinal risk: use cautiously in those with a history of ulcers or bleeding.
• Review cardiovascular status: monitor patients with hypertension or heart disease.
• Check for concurrent NSAID or anticoagulant use: increase risk of bleeding.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Ibuprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): heightened bleeding risk.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• Corticosteroids: increased ulceration potential.
• Lithium: possible elevation of lithium serum levels.
• Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may impair renal function.
• Diuretics: risk of reduced kidney perfusion.
• Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding.
• Antihypertensives: possible attenuation of blood‑pressure‑lowering effect.
• Oral hypoglycemics: may affect glucose control.